Clin2
NCT07329556Possibly a fitNot yet recruiting

Skin scan for sugar-related damage in rheumatic disease

Rheumatoid Arthritis (RAAnkylosing SpondylitisPsoriatic ArthritisReactive Arthritis (ReA)Crystal ArthropathiesConnective Tissue DiseasesFamilial Mediterranean Fever (FMF )

Part of Bones, joints & muscles, Genetic & congenital, Immune system & allergy, Infections, Skin clinical trials.

This study uses a special skin scanner to measure sugar-related damage in the body, which may be linked to inflammation. It compares people with rheumatic conditions to healthy volunteers to see if the scanner can help track or predict disease.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are 18 to 75 years old.
  • You have an inflammatory rheumatic disease (like rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or others) or you are a healthy volunteer.
  • You are willing to have a simple, non-invasive skin scan done.
  • You do not have diabetes, kidney disease, active cancer, or a recent acute infection.
  • You are not pregnant or breastfeeding, and you do not have major skin issues at the scan site (like large scars or tattoos).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06876064Recruiting
Tracking people at risk for rheumatoid arthritis

This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.

Montpellier, Hérault
NCT07416656Recruiting
Checking blood sugar test accuracy for arthritis patients on sulfasalazine

This study checks if the medicine sulfasalazine affects a blood sugar test (HbA1c) in people with inflammatory arthritis. If you have arthritis, take sulfasalazine, and have higher blood sugar or diabetes, this trial may help understand your glucose levels.

Silkeborg, Central Jutland
NCT07393217Not yet recruiting
Blood test for fibrosis in rheumatoid arthritis and scleroderma

This study looks at whether a blood test can measure a protein linked to tissue scarring in people with rheumatoid arthritis or scleroderma. It aims to find a simpler way to track disease activity.

Sohag
NCT07857993Not yet recruiting
Remote monitoring for rheumatoid arthritis flares

This study tests a smartphone-based app that tracks hand symptoms to help detect rheumatoid arthritis flares and how well treatment is working. It aims to give patients and doctors an easier way to manage the disease between visits.

Vienna
NCT07772466Not yet recruiting
Checking heart health in early rheumatoid arthritis

This study looks at people with very early rheumatoid arthritis to see if a simple blood test and an ultrasound of the neck can show early signs of heart artery damage. The goal is to catch heart disease risk sooner in RA patients.

NCT07150000Recruiting
Rheumatic disease research study for patients and healthy volunteers

This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.

Bonn, North Rhine-Westphalia

Hear when a new Ankylosing Spondylitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.